Chairperson
Dr. Salem AlShemmari
Consultant Hematologist
Director, Department of Medicine
Kuwait University
Kuwait
CME Accredited
Endorsed by ESH
Webinar
Lymphoma Debate
Explore the latest evidence, emerging therapies, and practical approaches in lymphoma management, with a focus on the evolving treatment of DLBCL.
- Date
- 7 July 2026
- Time and Format
- 8:00 PM GMT +4 (UAE Time) · Virtual
Event starts in
00
Days
00
Hours
00
Minutes
00
Seconds
7 July 2026 · 8:00 PM GMT +4 (UAE Time)
3
Expert Faculty
4
Live Sessions
1 Hour
Live and Interactive
CME
Accredited
Why attend
Join the debate
A focused scientific exchange bringing together leading haematology faculty to move from data to clinical practice. Hear the latest evidence, follow real case discussions, and take part in an open panel debate on the evolution of DLBCL management.
From data to practice
Translate the latest lymphoma evidence into everyday clinical decisions.
Real case discussions
Practical insight from practising haematologists across the region.
Live and interactive
An open faculty debate and audience Q and A.
Meet the experts
Faculty
Chairperson
Speaker
Dr. Nameer Al-Saadawi
Consultant Hematologist and Clinical Director of AD-BMT Program
Abu Dhabi Stem Cells Center
United Arab Emirates
Speaker
Dr. Ruba Taha
Consultant, Hematology-BMT Department, NCCCR
Hamad Medical Corporation (HMC)
Qatar
Programme
Agenda
7 July 2026 · 8:00 PM GMT +4 (UAE Time) · Virtual
-
8:00 to 8:05 PM
Welcome and Introduction
Dr. Salem AlShemmari
-
8:05 to 8:30 PM
From Data to Clinical Practice - Case Discussions
Dr. Nameer Al-Saadawi
-
8:30 to 8:50 PM
Evolution of DLBCL Management
Dr. Ruba Taha
-
8:50 to 9:00 PM
Q&A - Discussion
All faculty
Reserve your place
Registration is quick and free. Secure your seat at the Lymphoma Debate virtual session and receive joining details by email.
- CME accredited
- Live faculty panel
- No cost to attend
Endorsed by
Supported by
Managed by
